We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NBTX icon
126
Nanobiotix
NBTX
$1.49B
$1.49B $29.19 13%
OCUL icon
127
Ocular Therapeutix
OCUL
$1.45B
$1.45B $6.61 2.01%
ANAB icon
128
AnaptysBio
ANAB
$1.44B
$1.44B $48.10 0.33%
TYRA icon
129
Tyra Biosciences
TYRA
$1.43B
$1.43B $20.87 1.31%
INBX icon
130
Inhibrx
INBX
$1.43B
$1.43B $97.10 1.11%
ORIC icon
131
Oric Pharmaceuticals
ORIC
$1.41B
$1.41B $13.63 1.59%
AAPG icon
132
Ascentage Pharma
AAPG
$1.39B
$1.39B $14.92 8.69%
DMRA
133
Damora Therapeutics
DMRA
$1.34B
$1.34B $21.71 0.84%
NKTR icon
134
Nektar Therapeutics
NKTR
$1.32B
$1.32B $38.65 0.99%
TSHA icon
135
Taysha Gene Therapies
TSHA
$1.3B
$1.3B $4 2.91%
RAPP icon
136
Rapport Therapeutics
RAPP
$1.27B
$1.27B $26.53 5.87%
LBRX icon
137
LB Pharmaceuticals
LBRX
$1.27B
$1.27B $39.42 0.48%
GHRS icon
138
GH Research
GHRS
$1.27B
$1.27B $18.50 2.17%
SLN icon
139
Silence Therapeutics
SLN
$1.22B
$1.22B $19.66 0.05%
OMER icon
140
Omeros
OMER
$1.22B
$1.22B $16.86 3.69%
SNDX icon
141
Syndax Pharmaceuticals
SNDX
$1.21B
$1.21B $13.57 3.19%
AVLN icon
142
Avalyn Pharma
AVLN
$1.21B
$1.21B $27.25 8.52%
DRTS icon
143
Alpha Tau Medical
DRTS
$1.19B
$1.19B $12.90 4.3%
KARD
144
Kardigan Inc
KARD
$1.19B
$1.19B $12.74 0.86%
BCAX icon
145
Bicara Therapeutics
BCAX
$1.17B
$1.17B $17.61 1.68%
IMTX icon
146
Immatics
IMTX
$1.15B
$1.15B $7.54 1.95%
REPL icon
147
Replimune Group
REPL
$1.13B
$1.13B $11.99 2.3%
VOR icon
148
Vor Biopharma
VOR
$1.12B
$1.12B $18.94 0%
SPTX icon
149
Seaport Therapeutics
SPTX
$1.11B
$1.11B $20.76 5.22%
LTGO
150
Latigo Biotherapeutics
LTGO
$1.1B
$1.1B $16.57 1.41%
4 5
6
7 8

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.26T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $136B, Regeneron Pharmaceuticals (REGN) at $84.3B and Moderna (MRNA) at $80.9B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.